Shopping Cart
- Remove All
- Your shopping cart is currently empty
RD3-0028 is a potent and selective RSV replication inhibitor with an EC50 of 4.5 μM.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | RD3-0028 is a potent and selective RSV replication inhibitor with an EC50 of 4.5 μM. |
Targets&IC50 | RSV:(EC50)4.5 μM |
In vitro | RD3-0028 exhibits an effective concentration (EC50) of 4.5 μM and a significantly lower cytotoxicity, with a 50% cytotoxic concentration (CC50) of 271.0μM, outperforming ribavirin. It lacks inhibitory effects on the replication of measles virus, influenza A virus, herpes simplex virus types 1 and 2, and human cytomegalovirus. However, RD3-0028 effectively inhibits various RSV strains at concentrations ranging from 4.5 to 11.0 μM, as determined by the MTT method, demonstrating superior efficacy to ribavirin with lower EC50 values against these strains[1]. |
In vivo | Aerosols from reservoirs containing RD3-0028 (7 mg/mL; 2 h twice daily for 3 days) significantly reduce the pulmonary titer in RSV-infected mice, demonstrating that the minimal effective dose of RD3-0028 is considerably less than that of ribavirin, the only compound currently available for RSV disease. |
Molecular Weight | 168.28 |
Formula | C8H8S2 |
Cas No. | 3886-39-3 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.